Artificial pancreas: clinical study in Latin America without premeal insulin boluses
"Background: Emerging therapies such as closed-loop (CL) glucose control, also known as artificial pancreas (AP) systems, have shown significant improvement in type 1 diabetes mellitus (T1DM) management. However, demanding patient intervention is still required, particularly at meal times. To r...
Guardado en:
| Autores principales: | Sánchez-Peña, Ricardo, Colmegna, Patricio, Garelli, Fabricio, De Battista, Hernán, García Violini, Demián, Moscoso-Vásquez, Marcela, Rosales, Nicolás, Fushimi, Emilia, Campos-Náñez, Enrique, Breton, Marc, Beruto, Valeria, Scibona, Paula, Rodriguez, Cintia, Giunta, Javier, Simonovich, Ventura, Belloso, Waldo H., Cherñavvsky, Daniel, Grosembacher, Luis |
|---|---|
| Formato: | Ponencias en Congresos acceptedVersion |
| Lenguaje: | Inglés |
| Publicado: |
2019
|
| Materias: | |
| Acceso en línea: | http://ri.itba.edu.ar/handle/123456789/1653 |
| Aporte de: |
Ejemplares similares
-
Artificial Pancreas: first clinical trials in Argentina
por: Sánchez-Peña, Ricardo, et al.
Publicado: (2019) -
Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses
por: Sánchez Peña, Ricardo, et al.
Publicado: (2018) -
Control-oriented model with intra-patient variations for an artificial pancreas
por: Moscoso-Vásquez, Marcela, et al.
Publicado: (2020) -
Control no-híbrido de glucemia ensayado en pacientes ambulatorios con Diabetes Tipo 1
por: Garelli, Fabricio, et al.
Publicado: (2023) -
Invalidation and low-order model set for artificial pancreas robust control design
por: Bianchi, Fernando D., et al.
Publicado: (2019)